Immunotherapy and allogeneic stem cells transplantation

被引：0

作者：

de Fontbrune, Flore Sicre ^{[1
]}

Cavalieri, Doriane ^{[2
]}

Leclerc, Mathieu ^{[3
]}

Beckerich, Florence ^{[3
]}

Maury, Sebastien ^{[3
]}

de latour, Regis Peffault ^{[1
]}

N-Guyen, Stephanie ^{[4
]}

Bay, Jacques-Olivier ^{[2
]}

机构：

[1] GH Henri Mondor, Hematol Clin & Transplantat, Creteil, France

[2] CHU Clermont Ferrand, Serv Theapie Cellulaire & Hematol Clin Adulte, Site Estaing 1,Pl Lucie Aubrac, F-63000 Clermont Ferrand, France

[3] Hop St Louis, Serv Hematol Greffe Moelle, 1 Ave Claude Vellefaux, F-75475 Paris 10, France

[4] Univ Paris 06, Univ Sorbonne, AP HP,CNRS ERL8255,Serv Hematol Clin, Ctr Immunol & Malad Infect CIMI Paris,INSERM U113, Paris, France

来源：

BULLETIN DU CANCER | 2016年 / 103卷

关键词：

HLA typing; Allogeneic transplantation; Immunotherapy; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; DONOR LYMPHOCYTE INFUSIONS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CORD BLOOD TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; MINOR HISTOCOMPATIBILITY ANTIGENS; DE-THERAPIE-CELLULAIRE; REDUCED-INTENSITY; T-CELLS;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Allogeneic stem cell transplantations represent perfect example of immunotherapy. Its positive aspects are due to the graft versus tumor effect. Unfortunately, this therapeutic advantage is usually associated with graft versus host effects. While the mechanism of these two graft reactions remain unclear, this is possible to modulate these immunologic effects. The type of conditioning regimen, the source of donor and the use of donor cells after the transplantation may influence the toxicity and the tumor response, leading to a better optimization of the procedure. This paper is presenting all the parameters which may contribute to improve allogeneic stem cell transplantations.

引用

页码：S164 / S174

页数：11

共 50 条

[1] Immunotherapy by allogeneic stem cell transplantation
Ringden, Olle
ADVANCES IN CANCER RESEARCH, VOL 97, 2007, 97 : 25 - 60
[2] New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells
Waller, EK
Boyer, M
BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S20 - S24
[3] New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells
EK Waller
M Boyer
Bone Marrow Transplantation, 2000, 25 : S20 - S24
[4] Immunotherapy in allogeneic hematopoietic stem cell transplantation – not just a case for effector cells
A Troeger
R Meisel
T Moritz
D Dilloo
Bone Marrow Transplantation, 2005, 35 : S59 - S64
[5] Immunotherapy in allogeneic hematopoietic stem cell transplantation - not just a case for effector cells
Troeger, A
Meisel, R
Moritz, T
Dilloo, D
BONE MARROW TRANSPLANTATION, 2005, 35 (Suppl 1) : S59 - S64
[6] Allogeneic stem cell transplantation as immunotherapy for nonhematological cancers
Srinivasan, R
Barrett, J
Childs, R
SEMINARS IN ONCOLOGY, 2004, 31 (01) : 47 - 55
[7] T-Cell Depleted RIC Allogeneic Stem Cells Transplantation: A Platform for Immunotherapy
Raymakers, R.
Levenga, H.
Schattenberg, T.
Maas, F.
Esendam, B.
Fredrix, H.
de Witte, T.
Dolstra, H.
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S32 - S32
[8] Allogeneic transplantation of peripheral stem cells
Blaise, D
HEMATOLOGY AND CELL THERAPY, 1996, 38 (05): : 455 - 455
[9] The role of repeat transplantation of haemopoietic stem cells and adoptive immunotherapy in treatment of leukaemia relapsing following allogeneic transplantation
Locatelli, F
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) : 633 - 638
[10] Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation
Audehm, Stefan
Krackhardt, Angela M.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (11) : 691 - 696

← 1 2 3 4 5 →